Page last updated: 2024-12-06

xylenol orange

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Xylenol Orange is a pH indicator and chelating agent. It is a complex organic compound, typically synthesized by the reaction of 3,3'-dimethyl-4,4'-dihydroxyfuchsone with formaldehyde and sulfanilic acid. Xylenol Orange is known for its ability to form intensely colored complexes with metal ions, particularly those of transition metals. This property makes it valuable for applications in analytical chemistry, including spectrophotometric titrations, colorimetric analysis, and the determination of metal ion concentrations. The compound has also found applications in biological research, where it is used to study the interactions of metal ions with proteins and nucleic acids. Its complexation properties are crucial for various analytical and biological applications. The study of Xylenol Orange helps in understanding the nature of metal-ligand interactions, improving analytical techniques, and revealing insights into biological processes.'

xylenol orange: carboxylate anion which exhibits characteristic visible spectrum when attached to a metal [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID73041
SCHEMBL ID41934
MeSH IDM0067068

Synonyms (44)

Synonym
glycine, n,n'-[(1,1-dioxido-3h-2,1-benzoxathiol-3-ylidene)bis[(6-hydroxy-5-methyl-3,1-phenylene)methylene]]bis[n-(carboxymethyl)-
o-cresolphthalexon s
3,n-di-(carboxymethyl)aminomethyl]cresolsulfonephthalein
xylenol orange
nsc324982
glycine,n'-[[hydroxy(2-sulfophenyl)methylene]bis[(6-hydroxy-5-methyl-3,1-phenylene)methylene]]bis[n-(carboxymethyl)-, .gamma.-sultone
1611-35-4
nsc-324982
m-cresolphthalexon s
acetic acid,1-benzoxathiol-3-ylidenebis[(6-hydroxy-5-methyl-m-phenylene)methylenenitrilo]]tetra-, s,s-dioxide
glycine,n'-[3h-2,1-benzoxathiol-3-ylidenebis[(6-hydroxy-5-methyl-3,1-phenylene)methylene]]bis[n-(carboxymethyl)-, s,s-dioxide
2-[[5-[3-[3-[[bis(carboxymethyl)amino]methyl]-4-hydroxy-5-methyl-phenyl]-1,1-dioxo-2,1$l^{6}-benzoxathiol-3-yl]-2-hydroxy-3-methyl-phenyl]methyl-(carboxymethyl)amino]acetic acid
{[5-(3-{3-[(bis-carboxymethyl-amino)-methyl]-4-hydroxy-5-methyl-phenyl}-1,1-dioxo-1,3-dihydro-1.lambda.6-benzo[c][1,2]oxathiol-3-yl)-2-hydroxy-3-methyl-benzyl]-carboxymethyl-amino}-acetic acid
A810230
2-[[5-[3-[3-[[bis(2-hydroxy-2-oxoethyl)amino]methyl]-5-methyl-4-oxidanyl-phenyl]-1,1-bis(oxidanylidene)-2,1$l^{6}-benzoxathiol-3-yl]-3-methyl-2-oxidanyl-phenyl]methyl-(2-hydroxy-2-oxoethyl)amino]ethanoic acid
2-[[5-[3-[3-[[bis(carboxymethyl)amino]methyl]-4-hydroxy-5-methylphenyl]-1,1-dioxo-2,1$l^{6}-benzoxathiol-3-yl]-2-hydroxy-3-methylphenyl]methyl-(carboxymethyl)amino]acetic acid
cresol phthalexon s
glycine, n,n'-(3h-2,1-benzoxathiol-3-ylidenebis((6-hydroxy-5-methyl-3,1-phenylene)methylene))bis(n-(carboxymethyl)-, s,s-dioxide
acetic acid, (3h-2,1-benzoxathiol-3-ylidenebis((6-hydroxy-5-methyl-m-phenylene)methylenenitrilo))tetra-, s,s-dioxide
nsc 324982
s2vdy878qd ,
n,n'-(3h-2,1-benzoxathiol-3-ylidenebis((6-hydroxy-5-methyl-3,1-phenylene)methylene))bis(n-(carboxy methyl)glycine) s,s-dioxide
glycine, n,n'-((1,1-dioxido-3h-2,1-benzoxathiol-3-ylidene)bis((6-hydroxy-5-methyl-3,1-phenylene)methylene))bis(n-(carboxymethyl)-
3,3'-bis(n,n-di-(carboxymethyl)aminomethyl)cresolsulfonephthalein
einecs 216-553-8
unii-s2vdy878qd
FT-0633703
xylenol orange [mi]
acetic acid, ((.alpha.-hydroxy-o-sulfobenzylidene)bis((6-hydroxy-5-methyl-m-phenylene)methylenenitrilo))tetra-, .gamma.-sultone
phenolsulfonephthalein, 3',3''-bis((bis(carboxymethyl)amino)methyl)-5',5''-dimethyl-
SCHEMBL41934
DTXSID1061819
glycine,n,n'-[(1,1-dioxido-3h-2,1-benzoxathiol-3-ylidene)bis[(6-hydroxy-5-methyl-3,1-phenylene)methylene]]bis[n-(carboxymethyl)-
mfcd00014580
AKOS030228392
ORZHVTYKPFFVMG-UHFFFAOYSA-N
Q286281
2,2',2'',2'''-((((1,1-dioxido-3h-benzo[c][1,2]oxathiole-3,3-diyl)bis(6-hydroxy-5-methyl-3,1-phenylene))bis(methylene))bis(azanetriyl))tetraacetic acid
2-[[5-[3-[3-[[bis(carboxymethyl)amino]methyl]-4-hydroxy-5-methylphenyl]-1,1-dioxo-2,1lambda6-benzoxathiol-3-yl]-2-hydroxy-3-methylphenyl]methyl-(carboxymethyl)amino]acetic acid
D88656
3,3-bis[n,n-bis(carboxymethyl)aminomethyl]-o-cresolsulfonphthalein
CS-0169096
xylenol orange, indicator
2,2',2'',2'''-((((1,1-dioxido-3h-benzo[c][1,2]oxathiole-3,3-diyl)bis(6-hydroxy-5-methyl-3,1-phenylene))bis(methylene))bis(azanetriyl))tetraaceticacid

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" One was irradiated with an 18 MeV electron field to examine the dose-response linearity and obtain a calibration curve."( On the use of a novel Ferrous Xylenol-orange gelatin dosimeter for HDR brachytherapy commissioning and quality assurance testing.
Hourdakis, CJ; Karaiskos, P; Papagiannis, P; Pappas, EP; Peppa, V, 2018
)
0.48
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (139)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (5.04)18.7374
1990's26 (18.71)18.2507
2000's53 (38.13)29.6817
2010's47 (33.81)24.3611
2020's6 (4.32)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 52.42

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index52.42 (24.57)
Research Supply Index5.01 (2.92)
Research Growth Index5.05 (4.65)
Search Engine Demand Index83.13 (26.88)
Search Engine Supply Index2.01 (0.95)

This Compound (52.42)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (0.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other148 (99.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]